107 related articles for article (PubMed ID: 23337385)
1. Recurrence of differentiated thyroid cancer in the elderly.
Hollenbeak CS; Boltz MM; Schaefer EW; Saunders BD; Goldenberg D
Eur J Endocrinol; 2013 Apr; 168(4):549-56. PubMed ID: 23337385
[TBL] [Abstract][Full Text] [Related]
2. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
3. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
4. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
[TBL] [Abstract][Full Text] [Related]
5. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
6. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
McHenry C; Jarosz H; Lawrence AM; Paloyan E
Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
[TBL] [Abstract][Full Text] [Related]
7. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
8. Is thyroid cancer recurrence risk increased after transplantation?
Tisset H; Kamar N; Faugeron I; Roy P; Pouteil-Noble C; Klein M; Mourad G; Drui D; Do Cao C; Leenhardt L; Allix I; Bonichon F; Morelon E; Leboulleux S; Kelly A; Niccoli P; Toubert ME; Frimat L; Vantyghem MC; Bournaud C; Schlumberger M; Borson-Chazot F;
J Clin Endocrinol Metab; 2013 Oct; 98(10):3981-8. PubMed ID: 23884779
[TBL] [Abstract][Full Text] [Related]
9. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors affecting disease-specific survival in patients with recurrent and/or metastatic differentiated thyroid carcinoma detected by positron emission tomography/computed tomography.
Akkas BE; Demirel BB; Vural GU
Thyroid; 2014 Feb; 24(2):287-95. PubMed ID: 23750862
[TBL] [Abstract][Full Text] [Related]
11. Increasing incidence and characteristics of differentiated thyroid cancer in Huntington, West Virginia.
Merhy J; Driscoll HK; Leidy JW; Chertow BS
Thyroid; 2001 Nov; 11(11):1063-9. PubMed ID: 11762717
[TBL] [Abstract][Full Text] [Related]
12. Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer.
Vaisman F; Shaha A; Fish S; Michael Tuttle R
Clin Endocrinol (Oxf); 2011 Jul; 75(1):112-9. PubMed ID: 21521273
[TBL] [Abstract][Full Text] [Related]
13. Childhood and adolescent thyroid carcinoma.
Grigsby PW; Gal-or A; Michalski JM; Doherty GM
Cancer; 2002 Aug; 95(4):724-9. PubMed ID: 12209714
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
15. Recurrence and mortality in patients with differentiated thyroid carcinoma.
Noguchi M; Yagi H; Earashi M; Kinoshita K; Miyazaki I; Mizukami Y
Int Surg; 1995; 80(2):162-6. PubMed ID: 8530235
[TBL] [Abstract][Full Text] [Related]
16. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
[TBL] [Abstract][Full Text] [Related]
17. Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma.
Mazzaferri EL
Thyroid; 1997 Apr; 7(2):265-71. PubMed ID: 9133698
[TBL] [Abstract][Full Text] [Related]
18. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance.
Londero SC; Krogdahl A; Bastholt L; Overgaard J; Trolle W; Pedersen HB; Bentzen J; Schytte S; Christiansen P; Godballe C;
Thyroid; 2013 Sep; 23(9):1159-64. PubMed ID: 23427917
[TBL] [Abstract][Full Text] [Related]
20. Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcome.
Segal K; Shpitzer T; Hazan A; Bachar G; Marshak G; Popovtzer A
Otolaryngol Head Neck Surg; 2006 May; 134(5):819-22. PubMed ID: 16647541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
